Long COVID in the United States.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
17
02
2023
accepted:
26
09
2023
medline:
6
11
2023
pubmed:
2
11
2023
entrez:
2
11
2023
Statut:
epublish
Résumé
Although yet to be clearly identified as a clinical condition, there is immense concern at the health and wellbeing consequences of long COVID. Using data collected from nearly half a million Americans in the period June 2022-December 2022 in the US Census Bureau's Household Pulse Survey (HPS), we find 14 percent reported suffering long COVID at some point, half of whom reported it at the time of the survey. Its incidence varies markedly across the United States-from 11 percent in Hawaii to 18 percent in West Virginia-and is higher for women than men, among Whites compared with Blacks and Asians, and declines with rising education and income. It is at its highest in midlife in the same way as negative affect. Ever having had long COVID is strongly associated with negative affect (anxiety, depression, worry and a lack of interest in things), with the correlation being strongest among those who currently report long COVID, especially if they report severe symptoms. In contrast, those who report having had short COVID report higher wellbeing than those who report never having had COVID. Long COVID is also strongly associated with physical mobility problems, and with problems dressing and bathing. It is also associated with mental problems as indicated by recall and understanding difficulties. Again, the associations are strongest among those who currently report long COVID, while those who said they had had short COVID have fewer physical and mental problems than those who report never having had COVID. Vaccination is associated with lower negative affect, including among those who reported having had long COVID.
Identifiants
pubmed: 37917610
doi: 10.1371/journal.pone.0292672
pii: PONE-D-23-04744
pmc: PMC10621843
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0292672Informations de copyright
Copyright: © 2023 Blanchflower, Bryson. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
JAMA Psychiatry. 2022 Nov 1;79(11):1081-1091
pubmed: 36069885
JAMA Netw Open. 2022 Oct 3;5(10):e2238804
pubmed: 36301542
J Econ Behav Organ. 2020 Aug;176:461-488
pubmed: 32351257
Prev Med. 2023 Apr;169:107461
pubmed: 36813250
Clin Infect Dis. 2023 May 3;76(9):1636-1645
pubmed: 36542514
Open Forum Infect Dis. 2022 Sep 12;9(9):ofac464
pubmed: 36168555
BMJ. 2022 May 18;377:e069676
pubmed: 35584816
PLoS Med. 2021 Sep 28;18(9):e1003773
pubmed: 34582441
J Infect Dis. 2022 Nov 1;226(9):1593-1607
pubmed: 35429399
medRxiv. 2021 Mar 26;:
pubmed: 33791733
EClinicalMedicine. 2022 Dec 01;55:101762
pubmed: 36474804
Nat Med. 2022 Aug;28(8):1706-1714
pubmed: 35879616
PLoS One. 2022 Jul 22;17(7):e0269855
pubmed: 35867704
Nat Rev Microbiol. 2023 Mar;21(3):133-146
pubmed: 36639608